识别社区获得性肺炎治疗失败的预测因素:最新情况
Catia Cilloniz1,2,3, Alejandro Videla4, Juan M Pericàs5,6
1Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
在严重的社区获得性肺炎 (CAP) 中,治疗失败会增加死亡风险. 早期发现病因和危险因素对于及时干预和改善患者结果至关重要.
科学领域:
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
- 关键护理医学 关键护理医学
背景情况:
- 在社区获得性肺炎 (CAP),特别是严重病例中,治疗失败是一个重大问题.
- 它与并发症增加,住院时间延长和死亡率更高有关.
- 之前的报道显示,严重CAP的治疗失败率在4%至32%之间.
研究的目的:
- 审查最新的关于CAP治疗失败的科学证据.
- 专注于生物标志物在CAP治疗失败中的定义,风险因素,原因,病因和作用.
- 通过更好的管理策略,提供改善患者治疗结果的见解.
主要方法:
- 对CAP治疗失败的科学证据的文献综述.
- 来自PubMed.com数据的分析.
- 综合关于定义,风险因素,病因,病因学和生物标志物的信息.
主要成果:
- 在严重的CAP中,治疗失败需要一种细微的方法,超越最初的抗生素治疗.
- 识别故障的原因,风险因素和时间 (早期或晚期) 是至关重要的.
- 生物标志物可以帮助预测,诊断和监测治疗失败.
结论:
- 早期检测和适当的抗微生物治疗对于预防CAP治疗失败和降低死亡率至关重要.
- 为了有效预防和管理治疗失败,必须采取多学科的方法.
- 了解潜在的机制和宿主反应是改善CAP治疗失败结果的关键.
更多相关视频
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
相关概念视频
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia II: Pathophysiology
